Clinical Trials Directory

Trials / Completed

CompletedNCT04816253

Controlling Post-extraction Complications of Impacted Mandibular Third Molar

Methylprednisolone and Hyaluronic Acid Versus Each Agent Alone to Control Post-extraction Complications of Impacted Mandibular Third Molar

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
20 Years – 35 Years
Healthy volunteers
Accepted

Summary

Impacted mandibular 3rd molar will be extracted in all patients, then patients will be divided, according to material placed in extraction socket into 3 groups: control, hyaluronic acid and honey. Then post extraction complications will be evaluated

Detailed description

Impacted Mandibular third molar will be extracted under local anesthesia Through standard surgical flap elevation, after extraction and wound irrigation a material facilitate healing will be placed. According to material will be placed patients will be divide into 3 group: control ( no material, second group hyaluronic acid, third group ( honey).. then wound will be closed. Postoperative pain ( through visual analog scale) , edema, total dose of analgesic, mandibular movement (interincisal distance in mm) will be evaluated preoperative, 1,2,3,7, and 10 day after extraction

Conditions

Interventions

TypeNameDescription
DRUGNormal salineNormal saline irrigation and No other drug placed after extraction
DRUGHyaluronic acidImmediately after removal of impacted tooth (hyaluronic acid) placed in extraction socket
DRUGMethylprednisoloneMethylprednsolone will be injected half an hour preoperatively
DRUGMethylprednisolone and Hyaluronic acidMethylprednisolone will be injected half an hour preoperatively and Immediately after removal of impacted tooth (hyaluronic acid) placed in extraction socket

Timeline

Start date
2021-02-10
Primary completion
2021-06-20
Completion
2021-06-20
First posted
2021-03-25
Last updated
2021-07-22

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT04816253. Inclusion in this directory is not an endorsement.